Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Moderna
MRNA
|
$2.75B |
| 2 |
Coupang
CPNG
|
$1.09B |
| 3 |
Trade Desk
TTD
|
$793M |
| 4 |
BioNTech
BNTX
|
$736M |
| 5 |
Bilibili
BILI
|
$639M |
Top Sells
| 1 |
Tesla
TSLA
|
$7.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$1.39B |
| 3 |
Meta Platforms (Facebook)
META
|
$880M |
| 4 |
Amazon
AMZN
|
$773M |
| 5 |
NIO
NIO
|
$619M |
Sector Composition
| 1 | Consumer Discretionary | 31.93% |
| 2 | Healthcare | 19.13% |
| 3 | Technology | 17.13% |
| 4 | Communication Services | 14.58% |
| 5 | Financials | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Gentex
GNTX
$6.17B
| $18K | ﹤0.01% |
516
+38
| +8% | +$1.33K |
|
352
Hubbell
HUBB
$23.2B
| $18K | ﹤0.01% |
96
+4
| +4% | +$750 |
|
353
Thor Industries
THO
$5.91B
| $18K | ﹤0.01% |
133
+15
| +13% | +$2.03K |
|
354
XPEL
XPEL
$993M
| $18K | ﹤0.01% |
342
+16
| +5% | +$842 |
|
355
Transmedics
TMDX
$3.55B
| $17K | ﹤0.01% |
+400
| New | +$17K |
|
|
ONEM
356
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $17K | ﹤0.01% |
445
+13
| +3% | +$497 |
|
357
Blackrock
BLK
$172B
| $16K | ﹤0.01% |
21
| – | – |
|
358
Church & Dwight Co
CHD
$23.2B
| $16K | ﹤0.01% |
179
-5
| -3% | -$447 |
|
359
Nutanix
NTNX
$18.4B
| $16K | ﹤0.01% |
621
+35
| +6% | +$902 |
|
360
QuidelOrtho
QDEL
$1.89B
| $16K | ﹤0.01% |
128
+12
| +10% | +$1.5K |
|
|
DCT
361
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $16K | ﹤0.01% |
+355
| New | +$16K |
|
|
PLAN
362
DELISTED
Anaplan, Inc.
PLAN
| $16K | ﹤0.01% |
306
-1,871,634
| -100% | -$97.9M |
|
363
Johnson & Johnson
JNJ
$431B
| $15K | ﹤0.01% |
89
+1
| +1% | +$169 |
|
364
Lumentum
LITE
$9.92B
| $15K | ﹤0.01% |
168
-15
| -8% | -$1.34K |
|
365
Sarepta Therapeutics
SRPT
$1.93B
| $15K | ﹤0.01% |
205
+27
| +15% | +$1.98K |
|
366
Stanley Black & Decker
SWK
$11.6B
| $15K | ﹤0.01% |
77
-5
| -6% | -$974 |
|
367
Acadia Pharmaceuticals
ACAD
$4.3B
| $14K | ﹤0.01% |
544
+12
| +2% | +$309 |
|
368
Expeditors International
EXPD
$16.5B
| $14K | ﹤0.01% |
126
-4
| -3% | -$444 |
|
369
Mercury Systems
MRCY
$4.07B
| $14K | ﹤0.01% |
205
-12
| -6% | -$820 |
|
370
Nike
NKE
$111B
| $14K | ﹤0.01% |
105
-5
| -5% | -$667 |
|
|
NNDM
371
Nano Dimension
NNDM
$296M
| $14K | ﹤0.01% |
+1,600
| New | +$14K |
|
372
Rambus
RMBS
$8.11B
| $14K | ﹤0.01% |
699
+42
| +6% | +$841 |
|
373
Walmart
WMT
$805B
| $14K | ﹤0.01% |
303
-21
| -6% | -$970 |
|
374
Williams-Sonoma
WSM
$24.7B
| $14K | ﹤0.01% |
152
+16
| +12% | +$1.47K |
|
|
AXNX
375
DELISTED
Axonics, Inc. Common Stock
AXNX
| $14K | ﹤0.01% |
230
-19
| -8% | -$1.16K |
|